Arabic Arabic English English French French German German
dark

Moderna Completes Submission of Biologics License Application to the U.S. Food and Drug Administration for its COVID-19 Vaccine

Moderna, Inc. today announced it has completed the rolling submission process for its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the full licensure of the Moderna COVID-19 Vaccine for active immunization to prevent COVID-19 in individuals 18 years of age and older. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Applied UV Declares Monthly Preferred Stock Dividend

Next Post

New spinout to commercialise EEG biomarker for pain sensitivity

Related Posts
Total
0
Share